News Search

Topics

View All Topics

Showing 231 - 240 of 405 results.

Special Notice: New AD Treatment Lecanemab

September 28, 2022

A landmark study has shown lecanemab treatment to slow the course of Alzheimer’s disease. Lecanemab is now under consideration by the FDA but is not yet approved or available commercially.
Alzheimer Drug Trial Results Change 'Landscape'

September 28, 2022

Dr. Lawrence Honig, professor of neurology at Columbia University Irving Medical Center, speaks about the new Alzheimer drug trial results

Topic

Alzheimer's Disease
In Memoriam: Blair Ford, MD

September 27, 2022

With great sadness and regret, we share news of the death of our esteemed colleague, Blair Ford, MD.

Topic

In Memorium
Dr. Kiran T. Thakur Honored with 2022 Richard Mayeux Award

September 23, 2022

Dr. Kiran T. Thakur is an inpatient neurologist at Columbia University Irving Medical Center, with clinical expertise in neuroinfectious diseases and neuroimmunology.

Topic

Awards and Accomplishments
Welcome New Faculty - Dr. Maria Diaz

September 16, 2022

Meet Dr. Maria Diaz, an assistant professor of neurology at CUIMC, in the Division of Neuro-Oncology.

Topic

Neuro-Oncology
Desperate Patients Want a New ALS Drug. The FDA Is Not Sure It Works

By Laurie McGinley

September 9, 2022

Jinsy Andrews, an associate professor in the Department of Neurology at the Vagelos College of Physicians and Surgeons, speaks about the big difference between Aduhelm and AMX0035.

Topic

ALS
Melatonin and Kids

September 7, 2022

Dr. Arezou Heshmati, Associate Professor of Neurology and Pediatrics at CUMC, talks about melatonin and if it's safe to use for kids.

Topic

Child Neurology
Navigating Life with Dementia, written by Dr. James M. Noble

August 31, 2022

Dr. James M. Noble is an associate professor of neurology and dementia specialist in the Division of Aging and Dementia.

Topic

Alzheimer's Disease Research Center
Summer of Science

August 10, 2022

Students from historically Black colleges and universities (HBCUs) joined Columbia biomedical research laboratories for a summer of science, as part of CUIMC’s newest summer program

Topic

Diversity, Equity, Inclusion, and Accessibility Program News
Columbia Joins International Genetic Study of Alzheimer’s Disease in People of Hispanic and African Ancestry

July 25, 2022

"Hispanics and individuals of African ancestry have been significantly underrepresented in research of Alzheimer’s disease, although engaging underserved minorities is critical..." says Dr. Reitz

Topic

Alzheimer's Disease

News Search

Topics

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Topic

Pages